Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

IMMUNIZATION TO PREVENT ACUTE COPD EXACERBATIONS (IMPACE STUDY)

NCT03276754 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT03276754
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03276754 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
IMMUNIZATION TO PREVENT ACUTE COPD EXACERBATIONS (IMPACE STUDY)
Lead sponsor
Pfizer
Phase
Observational
Overall status
Terminated
Start date
November 30, 2017
Completion date
June 16, 2022
Enrollment
530 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

copd, pneumococcal infections